BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

772 related articles for article (PubMed ID: 30098163)

  • 21. Targeted next-generation sequencing identifies clinically relevant somatic mutations in a large cohort of inflammatory breast cancer.
    Liang X; Vacher S; Boulai A; Bernard V; Baulande S; Bohec M; Bièche I; Lerebours F; Callens C
    Breast Cancer Res; 2018 Aug; 20(1):88. PubMed ID: 30086764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrative analysis of the cancer genome atlas and cancer cell lines encyclopedia large-scale genomic databases: MUC4/MUC16/MUC20 signature is associated with poor survival in human carcinomas.
    Jonckheere N; Van Seuningen I
    J Transl Med; 2018 Sep; 16(1):259. PubMed ID: 30236127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Associations of
    Shen X; Zhao Y; Chen X; Sun H; Liu M; Zhang W; Jiang F; Li P
    Future Oncol; 2019 Jun; 15(16):1873-1894. PubMed ID: 30920860
    [No Abstract]   [Full Text] [Related]  

  • 24. Why
    Huang YJ; Cao ZF; Wang J; Yang J; Wei YJ; Tang YC; Cheng YX; Zhou J; Zhang ZX
    World J Clin Cases; 2021 Jun; 9(17):4143-4158. PubMed ID: 34141777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of Interleukin-1 Signaling Alterations of Colon Adenocarcinoma Identified Implications for Immunotherapy.
    Zhou X; Liu Y; Xiang J; Wang Y; Wang Q; Xia J; Chen Y; Bai Y
    Front Immunol; 2021; 12():665002. PubMed ID: 34367132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Somatic mutations in collagens are associated with a distinct tumor environment and overall survival in gastric cancer.
    Brodsky AS; Khurana J; Guo KS; Wu EY; Yang D; Siddique AS; Wong IY; Gamsiz Uzun ED; Resnick MB
    BMC Cancer; 2022 Feb; 22(1):139. PubMed ID: 35120467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comprehensive characterization of MUC16 mutations in lung adenocarcinoma for immunotherapies and prognosis: An observational study.
    Liu T; Wu L; Liu J; Chen H; Zhu B; Qiao D; Zhu Y; Liu T; Chen Q; Hu A
    Medicine (Baltimore); 2023 Nov; 102(44):e35481. PubMed ID: 37932988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor mutation burden as a biomarker in resected gastric cancer via its association with immune infiltration and hypoxia.
    Wang D; Wang N; Li X; Chen X; Shen B; Zhu D; Zhu L; Xu Y; Yu Y; Shu Y
    Gastric Cancer; 2021 Jul; 24(4):823-834. PubMed ID: 33687617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation between
    Hu S; Zhao X; Qian F; Jin C; Hou K
    Comput Math Methods Med; 2021; 2021():1522250. PubMed ID: 34603481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of a novel cell cycle-related gene signature predicting survival in patients with gastric cancer.
    Zhao L; Jiang L; He L; Wei Q; Bi J; Wang Y; Yu L; He M; Zhao L; Wei M
    J Cell Physiol; 2019 May; 234(5):6350-6360. PubMed ID: 30238991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bioinformatic analysis of the prognostic value of ZNF860 in recurrence-free survival and its potential regulative network in gastric cancer.
    Pan HX; Bai HS; Guo Y; Cheng ZY
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):162-170. PubMed ID: 30767193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of the Hippo transducer TAZ in association with WNT pathway mutations impacts survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy.
    Melucci E; Casini B; Ronchetti L; Pizzuti L; Sperati F; Pallocca M; De Nicola F; Goeman F; Gallo E; Amoreo CA; Sergi D; Terrenato I; Vici P; Di Lauro L; Diodoro MG; Pescarmona E; Barba M; Mazzotta M; Mottolese M; Fanciulli M; Ciliberto G; De Maria R; Buglioni S; Maugeri-Saccà M
    J Transl Med; 2018 Feb; 16(1):22. PubMed ID: 29402328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deep learning-based subtyping of gastric cancer histology predicts clinical outcome: a multi-institutional retrospective study.
    Veldhuizen GP; Röcken C; Behrens HM; Cifci D; Muti HS; Yoshikawa T; Arai T; Oshima T; Tan P; Ebert MP; Pearson AT; Calderaro J; Grabsch HI; Kather JN
    Gastric Cancer; 2023 Sep; 26(5):708-720. PubMed ID: 37269416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparison of clinicopathological features and prognosis between adenocarcinoma of esophagogastric junction and adenocarcinoma of gastric antrum].
    Zhu Z; Wang Y; Li F; Gao J; Han B; Wang R; Xue Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):149-155. PubMed ID: 30799537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High expression of miR-16 and miR-451 predicating better prognosis in patients with gastric cancer.
    Ren C; Chen H; Han C; Fu D; Wang D; Shen M
    J Cancer Res Clin Oncol; 2016 Dec; 142(12):2489-2496. PubMed ID: 27605261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glutathione Peroxidase 8 as a Prognostic Biomarker of Gastric Cancer: An Analysis of The Cancer Genome Atlas (TCGA) Data.
    Zhang X; Zhan D; Li Y; Wang H; Cheng C; Yao Y; Jia J
    Med Sci Monit; 2020 May; 26():e921775. PubMed ID: 32392186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular classification reveals the diverse genetic and prognostic features of gastric cancer: A multi-omics consensus ensemble clustering.
    Hu X; Wang Z; Wang Q; Chen K; Han Q; Bai S; Du J; Chen W
    Biomed Pharmacother; 2021 Dec; 144():112222. PubMed ID: 34607103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aberrant brain-expressed X-linked 4 (BEX4) expression is a novel prognostic biomarker in gastric cancer.
    Zhu C; Xiao D
    Medicine (Baltimore); 2020 Nov; 99(47):e23133. PubMed ID: 33217815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LAMB1 Is Related to the T Stage and Indicates Poor Prognosis in Gastric Cancer.
    Ran T; Chen Z; Zhao L; Ran W; Fan J; Hong S; Yang Z
    Technol Cancer Res Treat; 2021; 20():15330338211004944. PubMed ID: 33784890
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary Melanoma.
    Thomas NE; Edmiston SN; Alexander A; Groben PA; Parrish E; Kricker A; Armstrong BK; Anton-Culver H; Gruber SB; From L; Busam KJ; Hao H; Orlow I; Kanetsky PA; Luo L; Reiner AS; Paine S; Frank JS; Bramson JI; Marrett LD; Gallagher RP; Zanetti R; Rosso S; Dwyer T; Cust AE; Ollila DW; Begg CB; Berwick M; Conway K;
    JAMA Oncol; 2015 Jun; 1(3):359-68. PubMed ID: 26146664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.